Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
Markowitz, M., Zolopa, A., Squires, K., Ruane, P., Coakley, D., Kearney, B., Zhong, L., Wulfsohn, M., Miller, M. D., Lee, W. A.Volume:
69
Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkt532
Date:
May, 2014
File:
PDF, 393 KB
english, 2014